Related Experiment Videos
Clinical evaluation of a fully automated chromogenic method for prothrombin time compared with a conventional
Clinical Chemistry
|August 1, 1984
Summary
A new chromogenic method for prothrombin time (PT) testing shows high accuracy and reproducibility, comparable to the traditional clotting method. This sensitive assay is suitable for diagnosing various clinical conditions and can be adapted for automated analyzers.
Area of Science:
- Clinical Chemistry
- Hematology
- Diagnostic Assays
Background:
- Prothrombin time (PT) is a critical measure of the extrinsic and common coagulation pathways.
- Conventional clotting-based PT assays have limitations in sensitivity and automation.
- Chromogenic assays offer potential advantages in precision and adaptability.
Purpose of the Study:
- To evaluate the clinical utility of a novel chromogenic method for PT determination.
- To compare the performance of the chromogenic PT assay against the conventional clotting PT method across diverse clinical scenarios.
- To assess the sensitivity, correlation, and reproducibility of the chromogenic PT assay.
Main Methods:
- A chromogenic assay for PT determination was developed and validated.
- The chromogenic PT method was compared with the standard clotting PT method.
- Assays were performed on plasmas from healthy individuals, patients with liver disease, congenital factor deficiencies, and those on oral anticoagulant therapy.
Main Results:
- The chromogenic PT method demonstrated sensitivity to clotting factor deficiencies in the extrinsic and common pathways, excluding fibrinogen.
- Abnormal results in patients with liver disease were detected with a prevalence comparable to the clotting PT.
- High correlations were observed between the chromogenic and clotting PT methods for normal, deficient, and anticoagulated plasmas (r = 0.96 and r = 0.95, respectively).
- Excellent reproducibility was achieved, with between-assay coefficients of variation less than 3%.
Conclusions:
- The chromogenic PT method is a clinically useful and accurate alternative to the conventional clotting assay.
- Its high reproducibility and adaptability to centrifugal analyzers make it a strong candidate for replacing traditional PT testing.
- This assay provides reliable results across a spectrum of clinical conditions, including liver disease and anticoagulant therapy.